Clinical trial
A Phase II Study of Decitabine in Myelofibrosis
NCT00095784 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Decitabine in Myelofibrosis
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- September 29, 2004
- Completion date
- February 22, 2027
- Enrollment
- 21 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
primary myelofibrosis, secondary myelofibrosis